⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6691815 | 0.69 | — | — | |
| SCHEMBL942262 | 0.69 | — | — | |
| SCHEMBL19775398 | 0.69 | — | — | |
| SCHEMBL5101853 | 0.64 | — | — | |
| SCHEMBL54557 | 0.64 | — | — | |
| SCHEMBL3975114 | 0.64 | — | — | |
| SCHEMBL1751608 | 0.60 | — | — | |
| SCHEMBL423678 | 0.60 | — | — | |
| SCHEMBL4335791 | 0.59 | CA1 (0.50) | — | |
| SCHEMBL8971652 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1089 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6423486-B1 | — | — | None | — | — | US | claimed |
| US-20230226034-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR PHOTODERMATOSIS | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-07-20 | — | — | US | claimed |
| US-11680037-B2 | Branched fluorine-containing compound | DAIKIN INDUSTRIES, LTD. (JP) | 2023-06-20 | — | — | US | claimed |
| EP-4166139-A1 | PREVENTIVE OR THERAPEUTIC AGENT FOR ACTINIC SKIN DISEASE | Mitsubishi Tanabe Pharma Corporation (JP) | 2023-04-19 | — | — | EP | claimed |
| CN-115768428-A | Prophylactic or therapeutic agent for photodermatosis | 田边三菱制药株式会社 | 2023-03-07 | — | — | CN | claimed |
| CN-115594579-A | Branched fluorochemical compounds | 大金工业株式会社（JP） | 2023-01-13 | — | — | CN | claimed |
| US-20210355077-A1 | BRANCHED FLUORINE-CONTAINING COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2021-11-18 | — | — | US | claimed |
| EP-3381913-B1 | 2-(((PYRROLIDIN-3-YL)CARBONYL)AMINO)-1H-IMIDAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR 1 (MCR1) AGONISTS FOR TREATING RHEUMATOID ARTHRITIS | MITSUBISHI TANABE PHARMA CORP (JP) | 2021-03-31 | — | — | EP | claimed |
| CN-112194649-A | Pyrrolidine compounds and their use as melanocortin receptor agonists | 田边三菱制药株式会社 | 2021-01-08 | — | — | CN | claimed |
| EP-3150578-B1 | NOVEL PYRROLIDINE COMPOUND AND APPLICATION AS MELANOCORTIN RECEPTOR AGONIST | MITSUBISHI TANABE PHARMA CORP (JP) | 2020-10-14 | — | — | EP | claimed |
| EP-0355612-B1 | Furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-07-27 | — | — | EP | claimed |
| US-5308857-A | Antiulcer agents | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-05-03 | — | — | US | claimed |
| EP-0573761-A1 | Method of forming coloured images | FUJI PHOTO FILM CO., LTD. (JP) | 1993-12-15 | — | — | EP | claimed |
| US-5089491-A | Active against both gram-negative and gram-positive bacteria | EISAI CO., LTD. (JP) | 1992-02-18 | — | — | US | claimed |
| EP-0264091-B1 | 3-PROPENYLCEPHEM DERIVATIVE, PREPARATION THEREOF, CHEMICAL INTERMEDIATES THEREIN, PHARMACEUTICAL COMPOSITION AND USE | Eisai Co., Ltd. (JP) | 1992-02-05 | — | — | EP | claimed |
| US-4987138-A | HYPOTENSIVES | BEECHAM GROUP P.L.C. (GB) | 1991-01-22 | — | — | US | claimed |
| US-4921850-A | GRAMNEGATIVE AND GRAMPOSITIVE BACTERICIDE | EISAI CO., LTD. (JP) | 1990-05-01 | — | — | US | claimed |
| EP-0355612-A2 | Furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-02-28 | — | — | EP | claimed |
| EP-0355709-A2 | Derivatives of N-methylcarbamate, process for preparing the same and insecticide containing the same | AGRO-KANESHO CO., LTD. (JP) | 1990-02-28 | — | — | EP | claimed |
| EP-0264091-A2 | 3-Propenylcephem derivative, preparation thereof, chemical intermediates therein, pharmaceutical composition and use | Eisai Co., Ltd. (JP) | 1988-04-20 | — | — | EP | claimed |